Koh Young Technology said on Feb. 2 it recorded fourth-quarter 2025 revenue of 69.1 billion won and operating profit of 6.9 billion won. Revenue rose 36 percent from a year earlier and operating profit returned to the black. From the previous quarter, revenue rose 15 percent and operating profit increased 48 percent.

Overall results improved as sales of 3D inspection equipment and AI solutions rose, led by server customers in North America and Taiwan. Sales of 3D AOI, inspection equipment for component mounting, and AI solutions posted the company’s highest quarterly results on record. It attributed that to rising demand from AI server customers.

Full-year 2025 revenue rose 14.9 percent from a year earlier to 232.6 billion won. Operating profit surged 422 percent to 17.3 billion won. Net profit for the period fell 30 percent to 14.7 billion won.

The company said the licensing process last year was not as fast as expected, citing industry characteristics in which medical devices take a long time from basic research to commercialisation, overseas approvals and market entry. It forecast shipments would gradually expand from 2026, focused on global markets.

The company said its medical robot for brain surgery secured approval from Japan’s Ministry of Health, Labour and Welfare following approval from the U.S. Food and Drug Administration. It also said it is gradually expanding distribution channels such as agents and stepping up efforts to diversify sales channels and target markets.

A Koh Young official said, "As expanding demand for 3D inspection equipment and AI solutions is being confirmed, led by AI server customers, we expect the growth trend to continue."